Follow the people · Insider
Jorey Chernett
Jorey Chernett files insider transactions with the SEC as a 10% owner of Neuronetics (STIM). We hold 43 disclosed purchases and sales filed since 4 March 2026, 6 of them in the last 90 days.
- Files forSTIM
- Disclosed buys and sells43 in all, 6 in the last 90 days
- Last disclosure17 August 2026
Positions held
4 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 17 March 2026 — 14 August 202610% owner · Neuronetics (STIM)23 Form 4 lines · source: SEC Form 4
- Filed 13 August 2026 — 14 August 202610% owner · Starling Oncology (STLN)2 Form 4 lines · source: SEC Form 4
- Filed 13 March 2026 — 21 July 202610% owner · Oncology Institute (TOI)22 Form 4 lines · source: SEC Form 4
- Filed 3 March 2026 — 17 April 202610% owner · Airsculpt Technologies (AIRS)32 Form 4 lines · source: SEC Form 4
Everything they disclosed
79 entries, newest first — one per disclosure report, one per Form 4 line- ▲ bought on the open market 12,000 shares of Starling OncologySEC Form 417 August 2026Common Stock · traded 14 August 2026 · filed 17 August 2026
- ▼ sold on the open market 100 shares of Starling Oncology (a derivative holding)SEC Form 417 August 2026Call Option (STLN 19FEB27 $9C) · traded 13 August 2026 · filed 17 August 2026
- ▲ bought on the open market 14,000 shares of NeuroneticsSEC Form 417 August 2026Common Stock · traded 14 August 2026 · filed 17 August 2026
- ▼ sold on the open market 100 shares of Neuronetics (a derivative holding)SEC Form 417 August 2026Call Option (STIM 19FEB27 $5C) · traded 13 August 2026 · filed 17 August 2026
- ▲ bought on the open market 18,000 shares of Oncology InstituteSEC Form 422 July 2026Common Stock · traded 21 July 2026 · filed 22 July 2026
- ▲ bought on the open market 35,000 shares of NeuroneticsSEC Form 415 July 2026Common Stock · traded 14 July 2026 · filed 15 July 2026
- ▲ bought on the open market 15,000 shares of Oncology InstituteSEC Form 413 July 2026Common Stock · traded 10 July 2026 · filed 13 July 2026
- ▲ bought on the open market 18,000 shares of Oncology InstituteSEC Form 424 June 2026Common Stock · traded 23 June 2026 · filed 24 June 2026
- ▲ bought on the open market 12,000 shares of Oncology InstituteSEC Form 45 June 2026Common Stock · traded 4 June 2026 · filed 5 June 2026
- ▲ bought on the open market 5,000 shares of Oncology InstituteSEC Form 421 May 2026Common Stock · traded 19 May 2026 · filed 21 May 2026
- ▲ bought on the open market 33,500 shares of Oncology InstituteSEC Form 421 May 2026Common Stock · traded 20 May 2026 · filed 21 May 2026
- ▲ bought on the open market 30,000 shares of Oncology InstituteSEC Form 420 May 2026Common Stock · traded 19 May 2026 · filed 20 May 2026
- ▲ bought on the open market 100,000 shares of NeuroneticsSEC Form 420 May 2026Common Stock · traded 19 May 2026 · filed 20 May 2026
- ▲ bought on the open market 475,000 shares of NeuroneticsSEC Form 413 May 2026Common Stock · traded 12 May 2026 · filed 13 May 2026
- ▲ bought on the open market 100,000 shares of NeuroneticsSEC Form 422 April 2026Common Stock · traded 20 April 2026 · filed 22 April 2026
- ▲ bought on the open market 100,000 shares of NeuroneticsSEC Form 422 April 2026Common Stock · traded 21 April 2026 · filed 22 April 2026
- ▲ bought on the open market 40,000 shares of Airsculpt TechnologiesSEC Form 420 April 2026Common Stock · traded 17 April 2026 · filed 20 April 2026
- filed a transaction coded E in 2,004 shares of Airsculpt Technologies (a derivative holding)SEC Form 420 April 2026Call Option (AIRS 17APR26 $4C) · traded 17 April 2026 · filed 20 April 2026
- filed a transaction coded E in 2,000 shares of Airsculpt Technologies (a derivative holding)SEC Form 420 April 2026Call Option (AIRS 17APR26 $5C) · traded 17 April 2026 · filed 20 April 2026
- ▲ bought on the open market 20,000 shares of Airsculpt TechnologiesSEC Form 415 April 2026Common Stock · traded 14 April 2026 · filed 15 April 2026
- ▲ bought on the open market 20,000 shares of Oncology InstituteSEC Form 413 April 2026Common Stock · traded 9 April 2026 · filed 13 April 2026
- ▲ bought on the open market 60,000 shares of Airsculpt TechnologiesSEC Form 48 April 2026Common Stock · traded 7 April 2026 · filed 8 April 2026
- ▲ bought on the open market 90,000 shares of Airsculpt TechnologiesSEC Form 46 April 2026Common Stock · traded 3 April 2026 · filed 6 April 2026
- ▲ bought on the open market 500,000 shares of NeuroneticsSEC Form 430 March 2026Common Stock · traded 27 March 2026 · filed 30 March 2026
- ▲ bought on the open market 500,000 shares of NeuroneticsSEC Form 430 March 2026Common Stock · traded 27 March 2026 · filed 30 March 2026
- ▲ bought on the open market 27,429 shares of Oncology InstituteSEC Form 430 March 2026Common Stock · traded 27 March 2026 · filed 30 March 2026
- ▲ bought on the open market 27,429 shares of Oncology InstituteSEC Form 430 March 2026Common Stock · traded 27 March 2026 · filed 30 March 2026
- ▲ bought on the open market 385,442 shares of NeuroneticsSEC Form 430 March 2026Common Stock · traded 30 March 2026 · filed 30 March 2026
- ▲ bought on the open market 385,442 shares of NeuroneticsSEC Form 430 March 2026Common Stock · traded 30 March 2026 · filed 30 March 2026
- ▲ bought on the open market 125,000 shares of NeuroneticsSEC Form 427 March 2026Common Stock · traded 25 March 2026 · filed 27 March 2026
- ▲ bought on the open market 25,000 shares of NeuroneticsSEC Form 427 March 2026Common Stock · traded 26 March 2026 · filed 27 March 2026
- ▲ bought on the open market 125,000 shares of NeuroneticsSEC Form 427 March 2026Common Stock · traded 25 March 2026 · filed 27 March 2026
- ▲ bought on the open market 25,000 shares of NeuroneticsSEC Form 427 March 2026Common Stock · traded 26 March 2026 · filed 27 March 2026
- ▲ bought on the open market 50,000 shares of Oncology InstituteSEC Form 427 March 2026Common Stock · traded 26 March 2026 · filed 27 March 2026
- ▲ bought on the open market 50,000 shares of Oncology InstituteSEC Form 427 March 2026Common Stock · traded 26 March 2026 · filed 27 March 2026
- ▲ bought on the open market 125,000 shares of Oncology InstituteSEC Form 425 March 2026Common Stock · traded 24 March 2026 · filed 25 March 2026
- ▲ bought on the open market 125,000 shares of Oncology InstituteSEC Form 425 March 2026Common Stock · traded 24 March 2026 · filed 25 March 2026
- ▲ bought on the open market 50,000 shares of Airsculpt TechnologiesSEC Form 425 March 2026Common Stock · traded 23 March 2026 · filed 25 March 2026
- ▲ bought on the open market 2,255 shares of Airsculpt Technologies (a derivative holding)SEC Form 425 March 2026Call Option (AIRS 17APR26 $2C) · traded 23 March 2026 · filed 25 March 2026
- ▼ sold on the open market 6,547 shares of Airsculpt Technologies (a derivative holding)SEC Form 425 March 2026Call Option (AIRS 17APR26 $2C) · traded 23 March 2026 · filed 25 March 2026
- ▲ bought on the open market 2,255 shares of Airsculpt Technologies (a derivative holding)SEC Form 425 March 2026Call Option (AIRS 17APR26 $2C) · traded 23 March 2026 · filed 25 March 2026
- ▼ sold on the open market 6,547 shares of Airsculpt Technologies (a derivative holding)SEC Form 425 March 2026Call Option (AIRS 17APR26 $2C) · traded 23 March 2026 · filed 25 March 2026
- ▲ bought on the open market 2,004 shares of Airsculpt Technologies (a derivative holding)SEC Form 425 March 2026Call Option (AIRS 17APR26 $4C) · traded 23 March 2026 · filed 25 March 2026
- ▲ bought on the open market 2,000 shares of Airsculpt Technologies (a derivative holding)SEC Form 425 March 2026Call Option (AIRS 17APR26 $5C) · traded 23 March 2026 · filed 25 March 2026
- ▲ bought on the open market 2,004 shares of Airsculpt Technologies (a derivative holding)SEC Form 425 March 2026Call Option (AIRS 17APR26 $4C) · traded 23 March 2026 · filed 25 March 2026
- ▲ bought on the open market 2,000 shares of Airsculpt Technologies (a derivative holding)SEC Form 425 March 2026Call Option (AIRS 17APR26 $5C) · traded 23 March 2026 · filed 25 March 2026
- ▲ bought on the open market 50,000 shares of Airsculpt TechnologiesSEC Form 425 March 2026Common Stock · traded 23 March 2026 · filed 25 March 2026
- ▲ bought on the open market 25,000 shares of Oncology InstituteSEC Form 423 March 2026Common Stock · traded 20 March 2026 · filed 23 March 2026
- ▲ bought on the open market 25,000 shares of Oncology InstituteSEC Form 423 March 2026Common Stock · traded 20 March 2026 · filed 23 March 2026
- ▲ bought on the open market 40,000 shares of Airsculpt TechnologiesSEC Form 423 March 2026Common Stock · traded 20 March 2026 · filed 23 March 2026
- ▲ bought on the open market 40,000 shares of Airsculpt TechnologiesSEC Form 423 March 2026Common Stock · traded 20 March 2026 · filed 23 March 2026
- ▲ bought on the open market 169,472 shares of NeuroneticsSEC Form 423 March 2026Common Stock · traded 20 March 2026 · filed 23 March 2026
- ▲ bought on the open market 169,472 shares of NeuroneticsSEC Form 423 March 2026Common Stock · traded 20 March 2026 · filed 23 March 2026
- ▲ bought on the open market 607,400 shares of NeuroneticsSEC Form 420 March 2026Common Stock · traded 18 March 2026 · filed 20 March 2026
- ▲ bought on the open market 450,000 shares of NeuroneticsSEC Form 420 March 2026Common Stock · traded 19 March 2026 · filed 20 March 2026
- ▲ bought on the open market 607,400 shares of NeuroneticsSEC Form 420 March 2026Common Stock · traded 18 March 2026 · filed 20 March 2026
- ▲ bought on the open market 450,000 shares of NeuroneticsSEC Form 420 March 2026Common Stock · traded 19 March 2026 · filed 20 March 2026
- ▲ bought on the open market 77,702 shares of Airsculpt TechnologiesSEC Form 420 March 2026Common Stock · traded 19 March 2026 · filed 20 March 2026
- ▲ bought on the open market 77,702 shares of Airsculpt TechnologiesSEC Form 420 March 2026Common Stock · traded 19 March 2026 · filed 20 March 2026
- ▲ bought on the open market 531,000 shares of NeuroneticsSEC Form 418 March 2026Common Stock · traded 17 March 2026 · filed 18 March 2026
- ▲ bought on the open market 531,000 shares of NeuroneticsSEC Form 418 March 2026Common Stock · traded 17 March 2026 · filed 18 March 2026
- ▲ bought on the open market 83,000 shares of Airsculpt TechnologiesSEC Form 418 March 2026Common Stock · traded 17 March 2026 · filed 18 March 2026
- ▲ bought on the open market 83,000 shares of Airsculpt TechnologiesSEC Form 418 March 2026Common Stock · traded 17 March 2026 · filed 18 March 2026
- ▲ bought on the open market 263,000 shares of Oncology InstituteSEC Form 417 March 2026Common Stock · traded 13 March 2026 · filed 17 March 2026
- ▲ bought on the open market 60,985 shares of Oncology InstituteSEC Form 417 March 2026Common Stock · traded 16 March 2026 · filed 17 March 2026
- ▲ bought on the open market 75,000 shares of Oncology InstituteSEC Form 417 March 2026Common Stock · traded 17 March 2026 · filed 17 March 2026
- ▲ bought on the open market 263,000 shares of Oncology InstituteSEC Form 417 March 2026Common Stock · traded 13 March 2026 · filed 17 March 2026
- ▲ bought on the open market 60,985 shares of Oncology InstituteSEC Form 417 March 2026Common Stock · traded 16 March 2026 · filed 17 March 2026
- ▲ bought on the open market 75,000 shares of Oncology InstituteSEC Form 417 March 2026Common Stock · traded 17 March 2026 · filed 17 March 2026
- ▲ bought on the open market 105,848 shares of Airsculpt TechnologiesSEC Form 416 March 2026Common Stock · traded 16 March 2026 · filed 16 March 2026
- ▲ bought on the open market 105,848 shares of Airsculpt TechnologiesSEC Form 416 March 2026Common Stock · traded 16 March 2026 · filed 16 March 2026
- ▲ bought on the open market 88,000 shares of Airsculpt TechnologiesSEC Form 411 March 2026Common Stock · traded 11 March 2026 · filed 11 March 2026
- ▲ bought on the open market 88,000 shares of Airsculpt TechnologiesSEC Form 411 March 2026Common Stock · traded 11 March 2026 · filed 11 March 2026
- ▲ bought on the open market 45,600 shares of Airsculpt TechnologiesSEC Form 49 March 2026Common Stock · traded 6 March 2026 · filed 9 March 2026
- ▲ bought on the open market 45,600 shares of Airsculpt TechnologiesSEC Form 49 March 2026Common Stock · traded 6 March 2026 · filed 9 March 2026
- ▲ bought on the open market 80,000 shares of Airsculpt TechnologiesSEC Form 44 March 2026Common Stock · traded 3 March 2026 · filed 4 March 2026
- ▲ bought on the open market 30,000 shares of Airsculpt TechnologiesSEC Form 44 March 2026Common Stock · traded 4 March 2026 · filed 4 March 2026
- ▲ bought on the open market 80,000 shares of Airsculpt TechnologiesSEC Form 44 March 2026Common Stock · traded 3 March 2026 · filed 4 March 2026
- ▲ bought on the open market 30,000 shares of Airsculpt TechnologiesSEC Form 44 March 2026Common Stock · traded 4 March 2026 · filed 4 March 2026
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.